Clinical Trial Detail

NCT ID NCT03639714
Title A Study of a Personalized Neoantigen Cancer Vaccine
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Gritstone Oncology, Inc.
Indications

lung non-small cell carcinoma

gastroesophageal junction adenocarcinoma

transitional cell carcinoma

colorectal cancer

Therapies

GRT-C901 + GRT-R902 + Ipilimumab + Nivolumab

Age Groups: adult senior

Additional content available in CKB BOOST